Patents by Inventor Dolph Ellefson

Dolph Ellefson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mitigation of cutaneous injury with IL-12
    Patent number: 9925246
    Abstract: The present application relates to treatment of cutaneous wounds using IL-12. The methods of the invention result in improved wound closure. The methods comprise treating cutaneous wounds using topical, subcutaneous, and/or intramuscular administration of IL-12.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: March 27, 2018
    Assignee: NEUMEDICINES, INC.
    Inventors: Lena A. Basile, Dolph Ellefson, Timothy K. Gallaher
  • MITIGATION OF CUTANEOUS INJURY WITH IL-12
    Publication number: 20140205561
    Abstract: The present application relates to treatment of cutaneous wounds using IL-12. The methods of the invention result in improved wound closure. The methods comprise treating cutaneous wounds using topical, subcutaneous, and/or intramuscular administration of IL-12.
    Type: Application
    Filed: June 13, 2012
    Publication date: July 24, 2014
    Inventors: Lena A. Basile, Dolph Ellefson, Timothy K. Gallaher
  • Tagged epitope protein transposable element
    Publication number: 20060040382
    Abstract: A transposable element is provided that has a 3? and a 5? end. The transposable element includes a 5? recombining site 5? of a nucleic acid sequence encoding a selectable marker, a 3? recombining site 3? of the nucleic acid sequence encoding a selectable marker, a nucleic acid sequence encoding an MHC epitope 5? to the 5? recombining site or 3? to the 3? recombining site, and an insertion end comprising an inverted repeat sequence sufficient for integration of the transposable element at the 5? and the 3? end of the transposable element. In one embodiment, a transposable element is provided that has a 5? and a 3? end. The transposable element includes a 5? loxP sequence 5? of a nucleic acid encoding a selectable marker, a 3? loxP sequence 3? of a nucleic acid encoding the selectable marker, an MHC epitope 5? to the 5? loxP sequences or 3? of the 3? loxP sequence, an insertion end at the 5? end of the transposable element, and an insertion end at the 3? of the transposable element.
    Type: Application
    Filed: October 18, 2004
    Publication date: February 23, 2006
    Inventors: Fred Heffron, David Parker, Dolph Ellefson